Publicaciones en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (52)

2023

  1. Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  2. Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries

    Frontiers in Endocrinology, Vol. 13

  3. Characteristics and management of patients with SARS-CoV2 infection admitted to pediatric intensive care units: Data analysis of the Spanish national multicenter registry

    Pediatric Pulmonology, Vol. 58, Núm. 10, pp. 2916-2929

  4. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  5. Is collagen X marker (CXM) a useful index of growth velocity in children with chronic kidney disease?

    Pediatric Nephrology

2022

  1. Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation

    Kidney International Reports, Vol. 7, Núm. 4, pp. 797-809

2021

  1. Acute hypoxemic respiratory failure in children at the start of COVID-19 outbreak: A nationwide experience

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  2. Correction to: Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population (Orphanet Journal of Rare Diseases, (2021), 16, 1, (104), 10.1186/s13023-021-01729-0)

    Orphanet Journal of Rare Diseases

  3. Faecal calprotectin in children with multisystem inflammatory syndrome: A pilot case-control study

    Acta Paediatrica, International Journal of Paediatrics, Vol. 110, Núm. 7, pp. 2246-2248

  4. Molecular Mechanisms of Proteinuria in Minimal Change Disease

    Frontiers in Medicine, Vol. 8

  5. Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  6. Vitamin d status in pediatric and young adult cystic fibrosis patients. Are the new recommendations effective?

    Nutrients, Vol. 13, Núm. 12

2020

  1. A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units

    Intensive Care Medicine

  2. COVID-19 Gastrointestinal Manifestations Are Independent Predictors of PICU Admission in Hospitalized Pediatric Patients

    Pediatric Infectious Disease Journal, Vol. 39, Núm. 12, pp. E459-E462

  3. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

2019

  1. Food Protein-induced Enterocolitis Syndrome: Data from a Multicenter Retrospective Study in Spain

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 68, Núm. 2, pp. 232-236

2018

  1. Admission, discharge and triage guidelines for paediatric intensive care units in Spain

    Anales de Pediatria, Vol. 88, Núm. 5, pp. 287.e1-287.e11

  2. Admission, discharge and triage guidelines for paediatric intensive care units in Spain

    Medicina Intensiva, Vol. 42, Núm. 4, pp. 235-246

  3. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  4. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618